Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NOx content in the CSF. A different marker profile in four neurodegenerative diseases

Neurochemical Research

Volumn 33, Issue 9, 2008, Pages 1717-1723

  Boll, Marie Catherine ^a   Alcaraz Zubeldia, Mireya ^a   Montes, Sergio ^a   Rios, Camilo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Ceruloplasmin; Copper; Ferroxidase; Huntington's disease; Lateral amyotrophic sclerosis; Lipid peroxidation; Nitric oxide; Parkinson's disease

Indexed keywords

CERULOPLASMIN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; IRON; NITRATE; NITRIC OXIDE; NITRITE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUNTINGTON CHOREA; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CERULOPLASMIN; COPPER; HUMANS; HUNTINGTON DISEASE; LIPID PEROXIDATION; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; PARKINSON DISEASE; ROC CURVE; SUPEROXIDE DISMUTASE;

EID: 48449094910     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9610-3     Document Type: Article

References (35)

1. DL Price 1999 New order from neurological disorders Nature 399 suppl A3 A5
2. B Halliwell 1992 Reactive oxygen species in the central nervous system J Neurochem 59 1609 1623
3. H Ischiropoulos JS Beckman 2003 Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111 163 169
4. P Jenner AH Schapira CD Marsden 1992 New insights into the cause of Parkinson's disease Neurology 42 2241 2250
5. EA Schon G Manfredi 2003 Neuronal degeneration and mitochondrial dysfunction J Clin Invest 111 303 312
6. MBH Youdim D Ben Shachar S Yehuda P Riederer 1990 The role of iron in the Basal Ganglion Adv Neurol 53 155 162
7. DT Dexter P Jenner AHV Schapira CD Marsden 1992 Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia Ann Neurol 32 S94 S100
8. C Rios R Alvarez-Vega P Rojas 1995 Depletion of copper and manganese in brain after MPTP treatment of mice Pharmacol Toxicol 76 348 352
9. M Alcaraz-Zubeldia P Rojas C Boll C Rios 2001 Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice Neurochem Res 26 59 64
10. HS Pall AC Williams DR Blake 1987 Raised cerebrospinal-fluid copper concentration in Parkinson's disease Lancet 2 238 241
11. MC Boll J Sotelo E Otero M Alcaraz-Zubeldia C Rios 1999 Reduced ferroxidase activity in the CSF from patients with Parkinson's disease Neurosci Lett 265 155 158
12. Huntington's Disease Collaborative Research Group 1993 A novel gene containing a trinucleotid repeat that is unstable on Huntington's disease chromosomes Cell 72 971 983
13. G McKhann D Drachman M Folstein 1994 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease. Neurology 34 939 944
14. JD Rothstein M Van Kammen AI Levey J Martin JW Kuncl 1995 Selective loss of glial glutamate transporter GTL1 in amyotrophic lateral sclerosis Ann Neurol 38 73 84
15. C Zoia T Cogliati E Tagliabue 2004 Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease Neurobiol Aging 25 149 157
16. L Zecca M Rosati R Renella 1998 Nitrite and nitrate levels in cerebrospinal fluid of normal subjects J Neural Transm 105 627 633
17. R Naidoo ML Knapp 1992 Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions Clin Chem 38 2449 2454
18. DR Rosen T Siddique D Patterson 1993 Mutations in Cu/Zn superoxide dismutase are associated with familiar amyotrophic lateral sclerosis Nature 362 59 62
19. DJ Waggoner TB Bartnikas JD Gitlin 1999 The role of copper in neurodegenerative diseases Neurobiol Dis 6 221 230
20. ZL Harris Y Takahashi H Miyajima M Serizawa RTA McGiliwray JD Gitlin 1995 Aceruloplasminemia: molecular characterization of this disorder of iron metabolism Proc Natl Acad Sci USA 92 2539 2543
21. ME Alonso P Yescas B Cisneros 1997 Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population Clin Genet 51 225 230
22. Huntington Study Group 1996 Unified Huntington's disease rating scale: reliability and consistency Mov Disord 11 136 142
23. MF Folstein SE Folstein PR McHugh 1975 "Mini- mental state": a practical method for grading the cognitive state of subjects for the clinician J Psychiatr Res 12 189 198
24. JT Moroney E Bagiella DW Desmond 1997 Meta-analysis of the Hachinski Ischemic score in pathologically verified dementias Neurology 49 1096 1105
25. BR Brooks 1994 El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the World Federation of Neurology research group on neuromuscular diseases and the El Escorial "clinical limits of amyotrophic lateral sclerosis" workshop contributors J Neurol Sci 124 suppl 96 107
26. ALS CNTF Treatment Study Phase I-II Study Group (1996) The ALS functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53:141-147
27. MC Boll M Alcaraz-Zubeldia S Montes LM Murillo-Bonilla C Rios 2003 Raised nitrates level and low SOD activity in the CSF in sporadic ALS Neurochem Res 28 5 699 703
28. JMC Gutteridge B Halliwell 1990 The measurement and mechanism of lipid peroxidation in biological systems TIBS 15 129 135
29. AG Estevez N Spear SM Manuel 1998 Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture Prog Brain Res 118 269 280
30. P Brookes AL Levonen S Shiva 2002 Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species Free Rad Biol Med 33 755 764
31. JC Corona LB Tovar-y-Romo R Tapia 2007 Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis Expert Opin Ther Targets 11 1415 1428
32. H Hochstrasser P Bauer U Walter 2004 Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease Neurology 63 1912 1917
33. BN Patel RJ Dunn SY Jeong 2002 Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury J Neurosci 2215 6578 6586
34. TA Bayer G Multhaup 2005 Involvement of amyloid beta precursor protein (AbetaPP) modulated copper homeostasis in Alzheimer's disease J Alzheimers Dis 8 201 206
35. DR Brown 2001 Copper and prion disease Brain Res Bull 55 165 173